Aerie Pharma (AERI) Misses Q4 EPS by 12c

Aerie Pharma (NASDAQ: AERI) reported Q4 EPS of ($0.58), $0.12 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Growth isn't weak enough to truly undercut inflation pressures - BMO
• Warren Buffet's Berkshire stock target raised at UBS into earnings
• Intuitive Surgical (ISRG) PT Raised to $435 at Piper Sandler